US2018127274A1PendingUtilityA1
Treating Particles
Assignee: PERPETUUS RES & DEVELOPMENT LIMITEDPriority: Nov 12, 2013Filed: Dec 28, 2017Published: May 10, 2018
Est. expiryNov 12, 2033(~7.3 yrs left)· nominal 20-yr term from priority
H01J 37/32568B01J 2219/0809H01J 37/32018H01J 37/32192B01J 2219/0894C23C 16/517H05H 1/46C01B 32/168C01B 32/194C08K 9/00B01J 2219/1206B01J 19/126B01J 2219/0824C23C 16/26C23C 16/509C01P 2004/03B08B 6/00C01B 32/19C01B 32/05C09C 1/44H01J 37/023C09C 1/46C23C 16/4417C23C 16/513B01J 2219/0879B01J 19/08C23C 16/511B01J 2219/0818B01J 19/087H05H 2001/4697H05H 1/473H05H 1/4697
35
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating particles by disaggregating, deagglomerating, exfoliating, cleaning, functionalising, doping, decorating and/or repairing said particles, in which the particles are subjected to plasma treatment in a treatment chamber containing a plurality of electrodes which project therein and wherein plasma is generated by said electrodes which are moved during the plasma treatment to agitate the particles.
Claims
exact text as granted — not AI-modified1 . A method of treating particles by disaggregating, deagglomerating, exfoliating, cleaning, functionalising, doping, decorating and/or repairing said particles, in which the particles are subjected to plasma treatment in a treatment chamber containing a plurality of electrodes which project therein and wherein plasma is generated by said electrodes which are moved during the plasma treatment to agitate the particles.
2 . A method according to claim 1 in which the particles treated are graphite particles.
3 . A method according to claim 2 in which the graphite particles are exfoliated to produce graphene containing particles, preferably graphene nanoplatelets (GNPs).
4 . A method according to claim 1 in which the particles treated are nano-particles.
5 . A method according to claim 4 in which the nanoparticles are carbon nano-particles, preferably fullerenes such as carbon nanotubes (CNTs), or graphene containing nanoparticles such as GNPs.
6 . A method according to claim 1 in which glow discharge plasma is generated by the electrodes.
7 . A method according to claim 1 in which plasma is formed in a localised region around each electrode.
8 . A method according to claim 1 in which a gas or gaseous mixture is introduced into the chamber to sustain the plasma, in which said gas or gaseous mixture is introduced from each electrode.
9 . A method according to claim 1 in which the electrodes are moved at a speed which is varied during the course of the plasma treatment so as to control the interaction between the plasma generated by the electrodes and the particles.
10 . A method according to claim 1 in which at least a portion of the treatment chamber is rotated thereby causing the electrodes to move during the plasma treatment.
11 . Apparatus for treating particles in a method according to claim 1 including a treatment chamber containing a plurality of electrodes which project therein, each electrode for generating a plasma, in which said electrodes are moveable to agitate particles disposed in the treatment chamber.
12 . Apparatus according to claim 11 in which at least a portion of the treatment chamber is rotatable thereby to cause the electrodes to move thereby agitating particles disposed in the treatment chamber.
13 . Apparatus according to claim 12 in which the treatment chamber is rotatable around a longitudinal axis, and the electrodes are radially disposed around the longitudinal axis.
14 . Apparatus according to claim 11 in which three or more, and preferably between 3 and 20, electrodes project into the treatment chamber.
15 . A method of repairing defects in fullerene or graphene containing nanoparticles in which said nanoparticles are subjected to a plasma treatment wherein plasma is formed in a carbon containing gas or gaseous mixture including a carbon containing gas, the carbon containing gas being present in an amount sufficient to repair defects in said nanoparticles.
16 . A method according to claim 15 in which the plasma treatment is a plasma enhanced chemical vapour deposition (PECVD) process.
17 . A method according to claim 15 in which the carbon containing gas is a hydrocarbon, an alcohol or a halocarbon.
18 . A method according to claim 17 in which the carbon containing gas is methane, methanol, or carbon tetrachloride.
19 . A method according to claim 18 in which the plasma is formed in pure methane or in a gaseous mixture which consists essentially of methane.
20 . A method according to claim 15 in which the nanoparticles are CNTs or GNPs.Join the waitlist — get patent alerts
Track US2018127274A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.